Compare RCS & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCS | NUS |
|---|---|---|
| Founded | 1994 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.0M | 256.3M |
| IPO Year | N/A | 1996 |
| Metric | RCS | NUS |
|---|---|---|
| Price | $5.16 | $5.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 118.5K | ★ 634.7K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 10.12% | 3.36% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.14 |
| P/E Ratio | ★ N/A | $127.00 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $5.09 | $4.89 |
| 52 Week High | $8.00 | $14.62 |
| Indicator | RCS | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 34.45 | 44.48 |
| Support Level | $5.09 | $4.92 |
| Resistance Level | $5.67 | $5.43 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 5.00 | 35.08 |
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.